Microdosing GLP-1s: What the Clinical Evidence Actually Shows

Microdosing semaglutide and tirzepatide is an off-label trend with mixed evidence. The biology is plausible, but the clinical validation for microdoses specifically is thinner than the marketing suggests. Here is what the data actually shows.

Compounded vs Brand-Name Semaglutide in 2026: What Patients Should Actually Know

The FDA semaglutide shortage is over and compounding rules have changed. Some compounded forms remain available, others do not, and the source quality varies enormously. See what to ask before agreeing to either pathway in 2026.

The Women’s Health Initiative Reckoning: Why Estrogen Got Blamed for the Wrong Reasons

A 2002 trial scared a generation of women away from hormone therapy. Two decades of follow-up data have rewritten most of the original conclusions. See what the WHI actually found, what got distorted in the press, and what the current evidence supports.

The 7-Year Perimenopause Timeline: What Symptoms Show Up When

Perimenopause is a 7-year process with distinct phases, not a sudden event. Early symptoms look nothing like late ones, and the right intervention depends on where you are on the timeline. Here is the staging map most primary care offices skip.

HbA1c at 5.6 Is a Warning, Not a Pass: The Insulin-Hormone Connection No One Talks About

A “normal” HbA1c of 5.6 hides a decade of insulin dysfunction that drives most of midlife’s hormone problems. Fasting insulin and HOMA-IR catch it earlier. Here is the metabolic-hormone connection your annual physical is not testing for.

Cortisol Patterns in High-Performing Professionals: Why “Just Stress” Is the Wrong Diagnosis

A morning blood cortisol test cannot see the pattern that actually matters. HPA axis dysregulation in high-performing professionals shows up as blunted mornings, elevated evenings, or flat-line all day. Here is what each pattern looks like and why standard testing misses it.

Your TSH Is “Normal” but You Still Feel Hypothyroid: The Free T3 Reality

A normal TSH does not mean your thyroid is doing its job. The active hormone (free T3) has to be made through a conversion step that often fails under stress and inflammation. Here is why that gap explains so many “normal labs, terrible symptoms” cases.

SHBG, Reverse T3, and DHEA-S: The Hormone Labs Hiding in Plain Sight

Standard physicals run a thin hormone panel. Three markers (SHBG, reverse T3, and DHEA-S) explain most of the symptoms patients feel when their bloodwork comes back “fine.” Here is what each one measures, why it matters, and what to ask for.

The Cost of Fatigue: What Chronic Exhaustion Actually Costs High Earners Annually

Chronic fatigue costs high earners far more than they realize. Lost productivity, missed promotions, rising healthcare bills, and strained relationships all add up. Here’s what fatigue is really costing you.

Bioidentical vs. Synthetic Hormones: What the Research Actually Shows

Bioidentical or synthetic hormones? The WHI study scared millions of women away from all hormone therapy. Here’s what the research actually shows about both options.